-The Times of India NEW DELHI: The drug price regulator has capped prices of 30 medicines including antibiotics and those used in treatment of diabetes, tuberculosis and malaria. The move is expected to bring down prices of most of these medicines by 25-30%. However, in some cases the reduction could be by as much as 50%. The National Pharmaceutical Pricing Authority (NPPA), which has the mandate to regulate prices of essential medicines,...

-Economic and Political Weekly   Amendments proposed by the previous Congress-led union government to the Panchayat (Extension to Scheduled Areas) Act 1996 had the potential of improving upon this progressive legislation. Unfortunately, with its successor pursuing different priorities, the possibility of the amendments being passed remains rather low. Kamal Nayan Choubey (kamalnayanchoubey@gmail.com) is with the Nehru Memorial Museum and Library, New Delhi. A bill for an amendment to the Panchayat (Extension to Scheduled Areas)...

-The Indian Express The Congress may be quick to attack the ruling NDA government for attempting to dilute the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) since it came to power, and for its poor implementation this year, but the high-profile constituencies of Congress president Sonia Gandhi and party vice-president Rahul Gandhi have performed dismally under the scheme, ranking below the national average on most key parameters. MGNREGA, introduced in...

-HowIndiaLives.com The fall is more perceptible in states ruled by the Congress-led UPA than the ones ruled by BJP-led NDA The government's flagship rural employment guarantee scheme is on the decline. On almost every key metric, the scheme drafted under the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA)-which promises 100 days of employment a year to every rural household that demands it and Mandates payments of wages within 15 days-is showing...

-The Times of India NEW DELHI: The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India. The move, a first of its kind, is also likely to be applied on patented drugs that are already being sold in the country, an official source said. An inter-ministerial committee, evaluating the mechanism to negotiate prices of patented medicines, has recently sought detailed information about...